羅 爾維

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Randomized Controlled Trials 75%
3. Alcoholism 63%
4. Schizophrenia 43%
5. Taiwan 41%
6. Methamphetamine 40%
7. Genes 38%
8. GABA-A Receptors 38%
9. Confidence Intervals 37%
10. Systematic Reviews 32%
11. Psychotic Disorders 30%
12. Multigene Family 25%
13. Alleles 24%
14. Antipsychotic Agents 23%
15. Single Nucleotide Polymorphism 23%
16. Population 22%
17. Genotype 19%
18. gamma-Aminobutyric Acid 18%
19. Safety 17%
20. Chlorhexidine 17%
21. Odds Ratio 16%
22. Libraries 16%
23. PubMed 16%
24. Alcoholics 15%
25. Shared Decision Making 15%
26. Aromatherapy 14%
27. Restriction Fragment Length Polymorphisms 14%
28. Cohort Studies 14%
29. Alcohols 13%
30. Gene Frequency 13%
31. Heroin Dependence 13%
32. Incidence 13%
33. Control Groups 12%
34. Povidone-Iodine 12%
35. Atrial Fibrillation 12%
36. Dopamine D2 Receptors 12%
37. Fibrin Tissue Adhesive 11%
38. Local Anti-Infective Agents 11%
39. GABA Receptors 11%
40. Exons 11%
41. Acetylcysteine 10%
42. Therapeutics 10%
43. Databases 10%
44. Major Depressive Disorder 10%
45. Nails 9%
46. Sleep 9%
47. Antidepressive Agents 9%
48. Alcohol Dehydrogenase 9%
49. Hydroxymethylglutaryl-CoA Reductase Inhibitors 9%
50. lesinurad 9%